Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Naturally occurring protein fragment found in the brain inhibits key enzyme implicated in Alzheimer's disease

  • Ongoing recovery efforts take toll on hurricane survivors

  • Climbing a tree can improve cognitive skills, researchers say

  • Socially integrated women have lower suicide risk

  • Key factor for stability of capillaries in brain identified

  • Mechanism behind the lack of effectiveness of certain antagonist drugs discovered

  • Compliance with guidelines for treating brain injuries doesn't guarantee better outcomes

  • Brain surgery saved Russian general who helped defeat Napoleon: Scientists 'rewrite' history books

  • Movement tracking technology sheds light on different speech disorders in children

  • Adolescents with sleep problems more likely to self-harm

  •